Benzimidazole compounds (Fig. 1) 
INTRODUCTION
The Z?i's-benzimidazole drug Hoechst 33258 (H33258; Fig. 1 ) has been widely used as a fluorescent DNA stain and is well known to bind in the minor-groove of B-DNA, preferentially at ATrich regions. 1 In contrast to groove-binding of H33258, 2-phenylbenzimidazole compounds were found to intercalate between successive DNA base pairs. 2 This family of drugs is important as a starting compound for rational drug design and provides a good model system to investigate the molecular basis for DNA sequence recognition. In order to obtain further information, we have synthesized several benzimidazole compounds and studied the interaction of these compounds with DNA using spectroscopic (absorption, CD, and fluorescence) and viscosity measurements.
EXPERIMENTAL
Benzimidazole compounds (1~4; Fig. 1 ) were synthesized according to the method described in the literature 3 and purified by repeated recrystalhzations. 4 Calf thymus DNA (DNA) was purchased from Sigma. Absorption, CD, and fluorescence spectra were measured with a Hitachi U-3300 spectrophotometer, a Jasco J-720 spectropolarimeter, and a Hitachi MPF spectrophotofluorometer, respectively, as a function of the molar ratio of DNA base to drug (P/D). Flow dichroism arid viscosity measurements were car- ried out as described elsewhere. 5 Sonicated DNA (molecular weight of 2.5 x 10 5 ) was used for viscosity measurements. All measurements were made in 5 mM phosphate buffer (pH 6,9, 25°C) with NaCl added to give desired ionic strength.
RESULTS AND DISCUSSION
Absorption spectra of 1 and 2 upon binding to DNA showed a red-shift with a clear isosbestic point. Binding isotherms obtained from absorbance titrations were well-fitted by the site exclusion model; 6 the binding site sizes were 3 and 4 base-pairs for 1 and 2, respectively, and the binding constants {K) were found to be 1. ; all the CD spectra at high RD values were very similar in shape to corresponding absorption spectra. The absorption and CD spectral behavior suggests that 1 and 2 interact with DNA by intercalation, while 3 and 4 by groove binding.
In order to obtain more details on the binding interaction, we measured the flow dichroism, viscosity, and fluorescence energy transfer. The results are summarized in the following. The flow dichroism of all DNA-drug complexes was negative in the absorption region of DNA bases (220-300 nm), while negative for DNA-1 and DNA-2 complexes and positive for DNA-3 and DNA-4 complexes in the drug absorption band (300-450 nm) (Fig. 2) . The intrinsic viscosity of sonicated DNA in the presence of 1 or 2 increases with increasing the binding ratio, while that in the presence of 3 or 4 only slightly increases. An intercalation binding mode results in very short base to drug distances. Thus, the use of fluorescence energy transfer experiments gives an insight into the binding mode of drug. The enhancements of relative fluorescence yields due to energy transfer to bound drug from DNA bases were observed for DNA-1 and DNA-2 systems, but not for DNA-3 and DNA-4 systems. These results clearly indicate that 1 and 2 are intercalators, but 3 and 4 are groove-binders.
Semi-empirical (AMI) and ab initio (Gaussian 98) calculations show that the ring systems of 1 and 2 are nearly co-planar, whereas those of H33258, 3 and 4 do not adopt planar conformations. In conclusion, the binding mode of benzimidazole compounds varies from intercalation to groove binding, depending upon the number of benzimidazole rings (conformation and size of compounds).
